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ABSTRACT 
 
Embryonic stem cells are pluripotent cell lines with the capacity of self-renewal and a broad differentiation plastic-
ity. They are isolated from preimplantation embryos and can be cultured in vitro for long time without losing their pluripo-
tency. Embryonic stem cells can also differentiate in vitro with the proper combination of growth and differentiation fac-
tors, cells will differentiate into more advanced stages of embryogenesis generating different adult cell type. In the pre-
sent study, we induced the in vitro differentiation of mouse embryonic stem cells (line R1) into cardiomyocytes and neu-
ronal cells. These differentiations were evaluated by reverse transcription-polymerase chain reaction to verify presence 
of tissue-specific markers. 
Keywords: Embryonic stem cells, in vitro differentiation, embryonic stem cell culture. 
 
RESUMO 
 
Células-tronco embrionárias são linhagens celulares pluripotentes capazes de se multiplicar indefinidamente e 
com grande capacidade de diferenciação celular. São isoladas de embriões em estágio pré-implantacional e podem ser 
cultivadas por longo tempo em laboratório sem perder sua pluripotencialidade. Células-tronco embrionárias podem, 
ainda, se diferenciar in vitro através da adição de fatores de crescimento e diferenciação ao meio de cultivo. As células 
se diferenciarão em estágios mais avançados de embriogênese, gerando tipos diferentes de células adultas. No presen-
te estudo, induzimos a diferenciação in vitro de células-tronco embrionárias de camundongos (linhagem R1) em células 
de tecido cardíaco e nervoso. A diferenciação foi avaliada pela reação em cadeia da polimerase precedida de transcri-
ção reversa para verificar a presença de marcadores tecido-específicos. 
Unitermos: Células-tronco embrionárias, diferenciação in vitro, cultivo de células-tronco embrionárias. 
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Several systems are currently used to study 
differentiation of embryonic tissues, especially em-
bryonic stem cells (ES). ES cells were isolated for 
the first time from uncommitted cells of the inner 
cell mass of preimplantation blastocysts (1,2). This 
cell line shows a rapid growth in culture and prolif-
erates indefinitely (3). Propagated under specific 
growth conditions, they remain in an undifferenti-
ated state (4,5). When implanted into blastocysts, 
the ES cells contribute efficiently to both somatic 
and germ-line tissues (6). Because of the ability to 
generate tissues from all the three primary germ 
layers, ES cells are called pluripotent cells. The 
possibility to manipulate ES cells in vitro, and to 
introduce targeted mutations by homologous re-
combination, (7) promoted the possibility to gener-
ate animal models for diseases. One promising use 
of ES cells is the possibility to differentiate these 
cells in vitro, and later use them as a source for 
transplant. To achieve this aim, firstly ES cell lines 
have to be cultured in the presence of differentia-
tion-inhibiting factors to maintain them in an un-
committed stage. These differentiation-inhibiting 
factors are provided by mitotically inactivated 
feeder cells, either embryonic fibroblasts (8), or by 
addition of leukemia inhibitory factor (LIF) to the 
culture medium (9). In contrast, ES cells can be 
stimulated to differentiate in vitro into different cell 
types by adding specific differentiation-inducing 
substances, e.g. retinoic acid (RA) or dimethyl sul-
foxide (DMSO) (10,11). 
To promote in vitro ES cell differentiation, 
first the ES cells must form a complex three-
dimensional cell aggregate called embryoid bodies 
(EB). With the proper combination of growth and 
differentiation factors, cells within developing EB 
will differentiate into more advanced stages of em-
bryogenesis, generating different adult cell types. In 
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the present study, we induced the in vitro differen-
tiation of mouse ES cells (line R1) into cardiomyo-
cytes and neuronal cells. These differentiations 
were evaluated by reverse transcription-polymerase 
chain reaction (RT-PCR) to verify presence of tis-
sue-specific markers. 
 
MATERIAL 
 
Cells 
Mouse ES cells line R1 (12) were used as the 
stem cell source for the experiment. Embryonic 
mouse fibroblasts were extracted from fetuses of a 
pregnant isogenic BALB/c mice with 15 days of 
pregnancy. 
 
Undifferentiated ES cell culture conditions 
Embryonic mouse fibroblasts (EMFI) treated 
with mitomicin C were used as feeder layer. The 
cell culture medium used was D-MEM (GIBCO) 
supplemented with 15% fetal calf serum, 1% antibi-
otic penicillin/streptomycin, 1% LIF and 1% non-
essential amino acids (NEAA) (GIBCO). ES cells 
were maintained in these medium and incubated in 
a high-humidity, 37 °C incubator containing 5% 
CO2 and 95% air. Every 48 hours they were splited 
1:3 with trypsin ethylene diaminetetraacetic acid 
(EDTA) 0,5% (GIBCO) solution. 
 
In vitro differentiation induction protocols  
EB were produced applying the hanging drop 
method (13). EB were maintained in bacteriological 
dishes (non-adherent) during 7 days in Iscove’s 
medium enriched with 15% fetal calf serum, 1% 
NEAA, 1% penicillin/streptomycin solution. To 
induce in vitro differentiation of ES cells into car-
diac cells, we added 1% DMSO during the first 2 
days of the suspension culture. To obtain neuronal 
cells we added 10
-7 
M RA on the third, fourth and 
fifth days of the suspension culture. After the sev-
enth day of suspension culture the cells were put in 
culture dishes (adhesion culture) and analyzed in 3, 
7, 10, 13 and 16 days. 
 
Molecular analysis 
ES cell samples obtained from days 3, 7, 10, 
13 and 16 of in vitro cell differentiation system 
were collected in lysis buffer (4M guanidinium 
thiocyanate, 0.1 M TRIS-HCl pH 7.5, 1% β-
mercaptoethanol) and contained RNA were ex-
tracted by single step extraction method (14). In 
parallel RNA extracted from mouse cardiac and 
neuronal tissue were obtained in order to be a posi-
tive control for the molecular analysis. All mRNA 
was reverse transcribed and amplified using oli-
gonucleotide primers complementary and identical 
to the transcripts of the analyzed genes. The reverse 
transcription and amplification reactions were car-
ried out with Tth-polymerase (Perkin Elmer, Nor-
walk, USA) following the protocol supplied by the 
manufacturer. β-tubulin was used as housekeeping 
gene and the designed primer (5’primer 
GGAACATAGCCGTAAACTGC- 3’primer´-
TCACTGTGCCCTGAAACTTACC) was submit-
ted to 63 ºC of annealing temperature and 40 cycles 
in PCR reaction. To access ES cell differentiation to 
cardiac cells we searched for the expression of α-
major histocompatibility complex (MHC) (15). 
The products of the reverse transcription re-
actions were denatured, followed by 35 cycles of 
amplification (1-minute denaturation at 95 ºC, 30-s 
anneling at 64 ºC and 1-minute elongation at 72 ºC). 
In contrast, to analyze the ES cell differentiation 
into neuronal cells, expression of NEURO 68 gene 
using specific primer (5’primer-
GTTGGGAATAGGGCTCAATCT 3´primer- 
CCAGGAAGAGCAGACAGAGGT) was per-
formed. The products of reverse transcription were 
denatured, followed by 40 cycles of amplification 
(1-minute denaturation at 95 ºC, 30-s anneling at 63 
ºC and 1-minute elongation at 72 ºC). Additionally, 
the expression of synaptophysin RNA was accessed 
using the following oligonucleotides primers (5‘ 
primer-GCCTGTCTCCTTGAACACGAAC 
3’primer-TACCGAGAGAACAACAAAGGGC). 
PCR technique was conduced with 40 cycles of 
amplification (1-minute denaturation at 95 ºC, 30-s 
anneling at 60 ºC and 1-minute elongation at 72 ºC). 
Products of RT-PCR reaction were submitted to a 
2% agarose gel containing 0.35 µL of ethidium 
bromide and submitted to electrophoresis. 
 
RESULTS AND DISCUSSION 
 
Analysis of molecular biology results demon-
strated the expression of β-tubulin in all mRNA 
analyzed samples. These data suggest that the RNA 
extraction method and the RT-PCR were success-
fully conduced. 
The differentiation protocol applied to obtain 
cardiomyocytes from ES cells using 1% DMSO 
during the first 2 days of cell suspension culture 
demonstrated to be a simple, positive and low-cost 
method. Obtained cardiomyocytes presented in vitro 
morphological characteristics of cardiac tissue also 
expressed in the cardiac gene marker α-MHC (Fig-
ure 1) This gene encodes myosin heavy chain, a 
protein related to heart contraction function. It was 
also possible to detect a functional and physiologi-
cal characteristic of cardiac tissue cells when cell 
cultures were analyzed by optical microscope. In 
addition, it was possible to observe differentiated 
Embryonic stem cells 
 
 
Rev HCPA 2008;28(2) 98 
cardiomyocyte cluster cells promoting spontaneous 
contraction. 
 
 
Figure 1 - Cardiac differentiation. A) Cardiac-like cell morphology after 7 days of embryonic stem differentiation protocol. In the 
selected area it was possible to observe spontaneous contractions resembling cardiac muscle cells. B) 2% agarose gel. Reverse tran-
scription-polymerase chain reaction for myosin heavy chain. 1 - 100 bp DNA ladder; 2 - cDNA obtained from brain used as negative 
control; 3 - cDNA extracted from embryonic stem cell cultures without differentiation; 4 - cDNA obtained from differentiated em-
bryonic stem cell (day 3); 5 - differentiated embryonic stem cells (day 7); 6 - differentiated embryonic stem cells (day 10); 7 - differ-
entiated embryonic stem cells (day 13), 8 - differentiated embryonic stem cells (day 16); 9 - myosin gene positive control (cDNA 
extracted from mouse heart). 
 
 
When ES cells were submitted to differentiation protocol to induce neuronal cell differentiation it was possible to 
observe a number of differentiated cells that showed neuronal-like morphological characteristics (Figure 2). 
 
Figure 2 - Neurogenic differentiation. A) Neuronal-like cell morphology after 13 days of embryonic stem differentiation protocol. B) 
1% agarose gel. Reverse transcription-polymerase chain reaction (RT-PCR) Neuro68 gene: 1 - DNA ladder 100 bp; 2 - negative 
control (cDNA from heart); 3 - embryonic stem cells without differentiation; 4 - differentiated embryonic stem cells (day 3); 5 - 
differentiated embryonic stem cells (day 7); 6 - differentiated embryonic stem cells (day 10); 7 - differentiated embryonic stem cells 
(day 13); 8 - differentiated ES cells (day 16); 9- positive control (cDNA obtained from mouse brain). C) 1% agarose gel. RT-PCR for 
synaptophysin gene: 1 - DNA ladder; 2 - embryonic stem cells without differentiation; 3 - differentiated embryonic stem cells (day 
3), 4 - differentiated embryonic stem cells (day 7); 5 - differentiated embryonic stem cells (day 10); 6 - differentiated embryonic stem 
cells (day 13), 7 - differentiated embryonic stem cells (day 16); 8 - positive control (cDNA obtained from mouse brain). 
 
 
In parallel to morphological analysis, neu-
ronal-like cells also express the specific gene 
marker NEURO 68 (Figure 2). NEURO 68 gene 
encodes a protein from the neurofilaments, exclu-
sively expressed by neuronal cell types. Neuronal-
like obtained cells also showed the expression of the 
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synaptophysin gene products, which encodes a 
synaptic vesicle glycoprotein with four 
transmembrane domains. It is present in 
neuroendocrine cells and in virtually all neurons in 
the brain and spinal cord that participate in synaptic 
transmission (Figure 2). The synaptophysin gene 
expression initiated on day 7 of culture and en-
hanced during the culture period to the 16
th
 day. In 
addition, it is possible to observe that there was no 
detected synaptophysin expression on day 3 of ES 
cells cultured with the protocol to induce neuronal 
differentiation. The expression of NEURO 68 and 
synaptophysin genes clearly demonstrated the pos-
sibility of guiding embryonic cell differentiation 
from pluripotent cells to neuronal-like cells, consid-
ering that it was possible to observe neuronal mor-
phology in addition to expression of neuronal-
specific proteins. 
ES cells can efficiently differentiate in vitro 
into cardiomyocytes or neuronal cells. This process 
of in vitro cell differentiation can be spontaneously 
observed in EB, but the generated population cells 
is a mix of several cell types. At the moment, there 
is no consensus on a protocol to induce a pure cell 
type culture from ES cells. Trying to answer this 
question, many protocols have been proposed to 
guide the ES cell differentiation into a defined cell 
type. By adding specific growth factors, it is possi-
ble to increase the rate of specific cell type. We 
followed protocols to induce ES cell differentiation 
preferentially into cardiac and neuronal cell types as 
described by other authors (10,13,16) in order to 
establish the ES cell in vitro differentiation routine 
in our laboratory. 
Even with the possibility of in vitro differen-
tiating ES cells, there are several challenges to ES 
cell research and therapy (17). Some researchers 
have reported that long cultures of human ES cell 
lines do not maintain normal karyotypes (18,19). 
Furthermore, the formation of teratomas is associ-
ated with the undifferentiated state of ES cells. To 
circumvent the risk of tumor formation, protocols 
leading to a 100% differentiation, or efficient puri-
fication selection should be used. Methods using 
cell surface markers and cell sorting have been suc-
cessfully tested in animals (20). Another challenge 
in the use of ES for therapy is the potential immu-
nogenicity of ES cell lineages. 
In conclusion, although ES cells have the po-
tential and (as data shown here) are relatively easy 
and cheap to in vitro differentiation, there are major 
challenges to overcome to employ ES cells therapy. 
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